SCHEDULE 13G

Company

Scinai Immunotherapeutics Ltd.

Filed

September 22, 2017

Accession Number

0001079973-17-000551

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →